Your browser doesn't support javascript.
loading
The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey.
Jada, Stephen Raimon; Dusabimana, Alfred; Abd-Elfarag, Gasim; Okaro, Samuel; Brusselaers, Nele; Carter, Jane Y; Logora, Makoy Yibi; Rovarini, Jacopo Mattia; Newton, Charles R; Colebunders, Robert.
Afiliação
  • Jada SR; Amref Health Africa, Juba P.O. Box 410, South Sudan.
  • Dusabimana A; Global Health Institute, University of Antwerp, 2016 Antwerp, Belgium.
  • Abd-Elfarag G; Amsterdam Center for Global Health, Department of Paediatrics and Department of Global Health, Amsterdam UMC, 1105 AZ Amsterdam, The Netherlands.
  • Okaro S; Amsterdam Institute for Global Health and Development, 1105 AZ Amsterdam, The Netherlands.
  • Brusselaers N; Amref Health Africa, Juba P.O. Box 410, South Sudan.
  • Carter JY; Global Health Institute, University of Antwerp, 2016 Antwerp, Belgium.
  • Logora MY; Centre for Translational Microbiome Research, Karolinska Institutet, 17177 Stockholm, Sweden.
  • Rovarini JM; Amref Health Africa Headquarters, Nairobi P.O. Box 30125, Kenya.
  • Newton CR; Neglected Tropical Diseases Unit, Ministry of Health, Juba P.O. Box 410, South Sudan.
  • Colebunders R; Amref Health Africa, Juba P.O. Box 410, South Sudan.
Pathogens ; 11(4)2022 Mar 24.
Article em En | MEDLINE | ID: mdl-35456071
ABSTRACT
A two-phase survey of epilepsy was conducted in selected villages in Mundri West and East Counties (26 June-8 July, 2021), an onchocerciasis-endemic area in Western Equatoria State in South Sudan. In the first phase, households were visited by a trained research team to identify persons suspected to have epilepsy. In the second phase, persons suspected to have epilepsy were interviewed and examined by a clinician to confirm the diagnosis. A total of 364 households agreed to participate in the survey, amounting to 2588 individuals. The epilepsy screening questionnaire identified 91 (3.5%) persons with suspected epilepsy, of whom the diagnosis of epilepsy was confirmed by a clinician in 86 (94.5%). The overall prevalence of confirmed epilepsy was 3.3% (95% CI 2.7-4.1%), and of nodding syndrome was 0.9% (95% CI 0.6-1.4%). In 61 (16.8%) households there was at least one person with epilepsy. Only 1212 (46.9%) of 2583 people took ivermectin during the last distribution round in 2021. The annual epilepsy incidence was 77.3/100,000 (95% CI 9.4-278.9/100,000) and the annual epilepsy mortality was 251.2/100,000 (95% CI 133.8-428.7/100,000). In conclusion, a high prevalence and incidence of epilepsy was observed in villages in Mundri. Urgent action is needed to prevent children from developing onchocerciasis-associated epilepsy by strengthening the local onchocerciasis-elimination programme.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prevalence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article